š Ralph Lauren Upgraded, Vertex Initiated, Yum! Brands Upgraded and moreā¦
RJ Hamster
Ratings changes for Sangamo Therapeutics, bluebird bio, Verastem, Heron Therapeutics, Syros Pharmaceuticals, Cellectis, Vivid Seats and moreā¦Text āMarketBeatā to Ā 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Ā Learn More.
CEO Mark Zuckerberg sold 2,311 shares of the stock in a transaction dated Friday, December 27th. The shares were sold at an average price of $600.21, for a total transaction of $1,387,085.31. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.
Ralph Lauren (NYSE:RL) was upgraded by analysts at Argus from a āholdā rating to a ābuyā rating. They now have a $250.00 price target on the stock. This represents a 6.9% upside from the current price of $233.97.
Yum! Brands (NYSE:YUM) was upgraded by analysts at Argus from a āholdā rating to a ābuyā rating. They now have a $155.00 price target on the stock. This represents a 15.3% upside from the current price of $134.40.
Canoo (NASDAQ:GOEV) was downgraded by analysts at Stifel Nicolaus from a ābuyā rating to a āholdā rating. They now have a $0.50 price target on the stock, down previously from $4.50. This represents a 63.1% downside from the current price of $1.36.
Ducommun (NYSE:DCO) is now covered by analysts at Royal Bank of Canada. They set an āoutperformā rating and a $72.00 price target on the stock. This represents a 17.1% upside from the current price of $61.50.
RPT Realty (NYSE:RPT) is now covered by analysts at Janney Montgomery Scott. They set a ābuyā rating and a $4.00 price target on the stock. This represents a 36.5% upside from the current price of $2.93.
Treace Medical Concepts (NASDAQ:TMCI) is now covered by analysts at Lake Street Capital. They set a ābuyā rating and a $14.50 price target on the stock. This represents a 104.2% upside from the current price of $7.10.
Vertex (NASDAQ:VERX) is now covered by analysts at DA Davidson. They set a ābuyā rating and a $62.00 price target on the stock. This represents a 16.3% upside from the current price of $53.29.
Sign up for MarketBeat All Access to gain access to MarketBeatās full suite of research tools:
Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeatās trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See whatās happening in the market right now with MarketBeatās real-time news feed. Export data to Excel for your own analysis.
